Verona Pharma PLC
NASDAQ:VRNA

Watchlist Manager
Verona Pharma PLC Logo
Verona Pharma PLC
NASDAQ:VRNA
Watchlist
Price: 60.75 USD -4.32% Market Closed
Market Cap: 5.2B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+35%
Revenue
Forecast
+170%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

VRNA Price Targets Summary
Verona Pharma PLC

Wall Street analysts forecast VRNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VRNA is 81.94 USD with a low forecast of 72.72 USD and a high forecast of 97.65 USD.

VRNA Lowest Forecast
Wall Street Target
72.72 USD
20% Upside
VRNA Average Forecast
Wall Street Target
81.94 USD
35% Upside
VRNA Highest Forecast
Wall Street Target
97.65 USD
61% Upside
Lowest
Price Target
72.72 USD
20% Upside
Average
Price Target
81.94 USD
35% Upside
Highest
Price Target
97.65 USD
61% Upside
Verona Pharma PLC Competitors:
Price Targets
JUBLPHARMA
Jubilant Pharmova Ltd
45% Upside
1477
Ocumension Therapeutics
41% Upside
SAN
Sanofi SA
16% Upside
DMP
Dermapharm Holding SE
36% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
45% Upside
1477
Ocumension Therapeutics
41% Upside
SAN
Sanofi SA
16% Upside
DMP
Dermapharm Holding SE
36% Upside
688321
Shenzhen Chipscreen Biosciences Co Ltd
103% Upside
002603
Shijiazhuang Yiling Pharmaceutical Co Ltd
48% Upside
R
RHONEMA
Rhone Ma Holdings Bhd
8% Upside
COPN
Cosmo Pharmaceuticals NV
73% Upside

Revenue
Forecast

Revenue Estimate
Verona Pharma PLC

The compound annual growth rate of Verona Pharma PLC's revenue for the next 3 years is 170%.

N/A
Past Growth
170%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Verona Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Verona Pharma PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-53%
Average Miss
What are analyst estimates?

See Also

Summary
VRNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
VRNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VRNA stock valuation using valuation multiples.
Wall Street Estimates
VRNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VRNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is VRNA's stock price target?
Price Target
81.94 USD

According to Wall Street analysts, the average 1-year price target for VRNA is 81.94 USD with a low forecast of 72.72 USD and a high forecast of 97.65 USD.

What is Verona Pharma PLC's Revenue forecast?
Projected CAGR
170%

The compound annual growth rate of Verona Pharma PLC's revenue for the next 3 years is 170%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 243,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.